Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacific Biosciences of CaliforniaAccelerate DiagnosticsQuanterixFluidigmEyepoint Pharmaceuticals
SymbolNASDAQ:PACBNASDAQ:AXDXNASDAQ:QTRXNASDAQ:FLDMNASDAQ:EYPT
Price Information
Current Price$8.13$11.22$33.90$8.17$0.59
52 Week RangeBuyHoldBuyBuyHold
Beat the Market™ Rank
Overall Score1.01.71.31.52.3
Analysis Score1.43.22.53.43.2
Community Score2.82.62.23.12.7
Dividend Score0.00.00.00.00.0
Ownership Score1.02.01.01.05.0
Earnings & Valuation Score0.00.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$6.25$18.00$37.67$13.33$3.50
% Upside from Price Target-23.12% downside60.43% upside11.11% upside63.20% upside492.32% upside
Trade Information
Market Cap$1.26 billion$632.30 million$964.12 million$582.65 million$73.99 million
Beta2.032.571.782.161.13
Average Volume2,189,477411,982194,6083,337,9071,321,056
Sales & Book Value
Annual Revenue$90.89 million$9.30 million$56.73 million$117.24 million$20.36 million
Price / Sales13.8167.9916.994.973.63
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.36 per share($0.14) per share$4.59 per share$2.21 per share$0.08 per share
Price / Book22.58-80.147.393.707.39
Profitability
Net Income$-84,130,000.00$-84,310,000.00$-40,800,000.00$-64,790,000.00$-56,790,000.00
EPS($0.55)($1.55)($1.63)($0.53)($0.48)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-61.85%-803.60%-73.39%-48.46%-229.34%
Return on Equity (ROE)-150.00%-5,681.44%-35.42%-23.91%-452.45%
Return on Assets (ROA)-41.97%-63.72%-25.83%-12.76%-67.31%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.07%0.41%12.63%
Current Ratio1.15%10.13%6.05%2.05%4.16%
Quick Ratio1.03%9.27%5.32%1.55%3.76%
Ownership Information
Institutional Ownership Percentage72.46%51.50%71.50%86.68%48.67%
Insider Ownership Percentage11.00%44.40%25.40%2.64%35.95%
Miscellaneous
Employees40128717753555
Shares Outstanding154.41 million56.36 million28.44 million71.32 million125.22 million
Next Earnings Date11/5/2020 (Estimated)11/5/2020 (Estimated)11/13/2020 (Estimated)11/3/2020 (Estimated)11/5/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.